International cooperation for the cure and prevention of severe hemoglobinopathies

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 6, 2013, Pages 419-423

  Faulkner, Lawrence B ^a   Uderzo, Cornelio ^a,b   Masera, Giuseppe ^b  

^a Cure2Children Foundation   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

bone marrow transplantation; international cooperation; thalassemia

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ALPHA THALASSEMIA; APLASTIC ANEMIA; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FANCONI ANEMIA; FEASIBILITY STUDY; FETUS HYDROPS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HEMOGLOBINOPATHY; HISTOCOMPATIBILITY; HUMAN; INDIA; INTERNATIONAL COOPERATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PAKISTAN; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; THALASSEMIA; THALASSEMIA MAJOR;

ASIA; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; DEVELOPING COUNTRIES; HUMANS; INDIA; INTERNATIONAL COOPERATION; MIDDLE EAST; PACIFIC ISLANDS; PAKISTAN;

EID: 84881480318     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31829cd920     Document Type: Review

References (34)

1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Available at: http://www.who.int/bulletin/volumes/ 86/6/06-036673/en/Accessed June 11, 2013.
2. Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115:4331-4336.
3. Ahmed S, Saleem M, Modell B, et al. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med. 2002;347:1162-1168.
4. Rund D, Rachmilewitz E. b-Thalassemia. N Engl J Med. 2005; 353:1135-1146.
5. Worldmapper: population under 15 years. Available at: http://sasi.group.shef.ac.uk/worldmapper/display.php?selected=5. Accessed June 11, 2013.
6. Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011;118:3479-3488.
7. Di Marco V, Capra M, Angelucci E, et al. Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood. 2010;116: 2875-2883.
8. Mehta PA, Faulkner LB. Hematopoietic cell transplantation for thalassemia: a global perspective. Biol Blood Marrow Transplant. 2013;19(suppl):S70-S73.
9. Angelucci E. Hematopoietic stem cell transplantation in thalassemia. Hematology Am Soc Hematol Educ Program. 2010;2010:456-462.
10. Cheuk DKL, Mok ASP, Lee ACW, et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant. 2008;42:319-327.
11. Leelahavarong P, Chaikledkaew U, Hongeng S, et al. A costutility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. BMC Health Serv Res. 2010;10:209-221.
12. Baki Y. Endocrine late effects post-haematopoietic stem cell transplant (HSCT) in children with haemoglobinopathies. Available at: http://registration. akm.ch/einsicht.php?XNAB STRACT-ID=169651&XNSPRACHE-ID=2&XNKONGR ESS-ID=179&XNMASKEN-ID=900#. Accessed June 11, 2013.
13. Caocci G, Efficace F, Ciotti F, et al. Prospective assessment of health-related quality of life in pediatric patients with betathalassemia following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:861-866.
14. Ruggeri A, Eapen M, Scaravadou A, et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant. 2011;17:1375-1382.
15. Bashey A, Zhang Xu, Sizemore CA, et al. T-cell-replete HLAhaploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013;31:1310-1316.
16. Sodani P, Isgrò A, Gaziev J, et al. Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. Blood. 2010;115:1296-1302.
17. Bolañ os-Meade J, Fuchs EJ, Luznik L, et al. HLA-haploidentical bone marrow transplantation with post-transplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood. 2012;120:4285-4291.
18. Marziali M, Isgrò A, Gaziev J, et al. Hematopoietic stem cell transplantation in thalassemia and sickle cell disease: experience of Mediterranean Institute of Hematology in a multiethnic population. Mediterr J Hematol Infect Dis. 2009;1: e2009027.
19. Faulkner L, Yaqub N, Khalid SK, et al. Transplantation in low resource countries. Thalassemia Reports. 2011;1:30-33.
20. Hsieh MM, Fitzhugh CD, Tisdale JF. Allogeneic hematopoietic stem cell transplant for sickle cell disease: the time is now. Blood. 2011;118:1197-1207.
21. El Missiry M. Free Sibling Compatibility Test for Bone Marrow Transplantation by Cure2Children. Available at: http://www. cure2children.org/ content/free-sibling-compatibility-test-bonemarrow-transplantation- cure2children. Accessed June 11, 2013.
22. Ansari SH, Shamsi TS, Ashraf M, et al. Efficacy of hydroxyurea in providing transfusion independence in b-thalassemia. J Pediatr Hematol Oncol. 2011;33:339-343.
23. Zamani F, Shakeri R, Eslami S-M, et al. Hydroxyurea therapy in 49 patients with major beta-thalassemia. Arch Iran Med. 2009;12:295-297.
24. Bradai M, Abad MT, Pissard S, et al. Hydroxyurea can eliminate transfusion requirements in children with severe betathalassemia. Blood. 2003;102:1529-1530.
25. Fucharoen S, Siritanaratkul N, Winichagoon P, et al. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. Blood. 1996;87:887-892.
26. George B, Mathews V, Viswabandya A, et al. Infections in children undergoing allogeneic bone marrow transplantation in India. Pediatr Transplant. 2006;10:48-54.
27. Kumar R, Naithani R, Mishra P, et al. Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India. BoneMarrow Transplant. 2009;43:115-119.
28. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143-1238.
29. Svahn B-M, Remberger M, Myrbäck K-E, et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood. 2002;100:4317-4324.
30. Solomon SR, Matthews RH, Barreras AM, et al. Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM. Bone Marrow Transplant. 2010;45:468-475.
31. Mullan F. The metrics of the physician brain drain. N Engl J Med. 2005;353:1810-1818.
32. Masera G, Baez F, Biondi A, et al. North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet. 1998;352:1923-1926.
33. Masera G. The "La Mascota" Twinning Program Between Monza (Italy) and Managua (Nicaragua): A 23-year Experience. In: Reaman GH , Smith, FO, eds. Childhood Leukemia: A Practical Handbook. 2011: 309-313. Available at: http://books.google.it/books?id=7PguSZ1LLq4C&printsec=front cover.
34. McGrath E, FACT-JACIE. International Standards for Cellular Therapy Product Collection, Processing and Administration. 4th ed. FACT-JACIE. Available at: http://www.jacie.org/document-centre/Standards%204.1%20ed.pdf?attredirects= 0; 2012.